It is currently Fri Feb 27, 2015 1:19 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Yawning

Yawning Saves Your Brain From Overheating
Posted by huehueteotl on June 25th, 2007

The next time you “catch a yawn” from someone across the room, you’re not copying their sleepiness, you’re participating in an ancient, hardwired ritual that might have evolved to help groups stay alert as a means of detecting danger. That’s the conclusion of University at Albany researchers Andrew C. Gallup and Gordon G. Gallup, Jr. in a study outlined in the May ...
Read more : Yawning | Views : 1817 | Replies : 5 | Forum : General Discussion


Pipex

Promising prescription: $5.5B market waiting as Pipex tests 2 drugs By Andrew Dietderich

June 25, 2007

An Ann Arbor-based company that’s moving to the American Stock Exchange today plans to tap at least two drug markets that could be worth a total of $5.5 billion annually, using drugs licensed from the University of Michigan and the University of California at Los Angeles.

Two weeks ago, Pipex Pharmaceuticals Inc. (Amex: PP) received $5 million from the ...
Read more : Pipex | Views : 2049 | Replies : 10 | Forum : Drug Pipeline


UCB and Biogen Idec's Oral VLA-4 Antagonist (CDP323) Enters

UCB and Biogen Idec's Oral VLA-4 Antagonist (CDP323) Enters Phase II Development for Multiple Sclerosis

Brussels (Belgium) and Cambridge, MA (USA) - June 26, 2007- 7:00 am CET - UCB (Euronext Brussels: UCB) and Biogen Idec (NASDAQ: BIIB) today announced the initiation of a Phase II study of CDP323 - an oral VLA-4 antagonist - under development for relapsing-remitting multiple sclerosis (MS). The double-blind, randomized Phase II study commenced this week with dosing of the ...
Read more : UCB and Biogen Idec's Oral VLA-4 Antagonist (CDP323) Enters | Views : 1055 | Replies : 0 | Forum : General Discussion


effexor-xr//

i was proscribed effexor xr today for anxiety..was wondering it anyone had anything positive or negative to say about it? it does say at wipedia that you should take if you take drugs that it a cns depressant..i take avonex...anything that anybody knows about this would be great...thanks
Read more : effexor-xr// | Views : 1484 | Replies : 6 | Forum : General Discussion


CDP323

Phase II has started and, interestingly, it is for sufferers for whom interferon has failed.

UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II Development for MS 26 June 2007

UCB and Biogen Idec today announced the initiation of a Phase II study of CDP323 - an oral VLA-4 antagonist - under development for relapsing-remitting multiple sclerosis (MS). The double-blind, randomised Phase II study commenced this week with dosing of the first patient. ...
Read more : CDP323 | Views : 1140 | Replies : 0 | Forum : Drug Pipeline


ACTRIMS

ACTRIMS was only a one day event this year, but covered some interesting subjects. Here is a summary from the NMSS.

http://www.nationalmssociety.org/site/P ... 007jun22_2
Read more : ACTRIMS | Views : 957 | Replies : 0 | Forum : General Discussion


News on the Tovaxin Extension Trials

Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin™ for Multiple Sclerosis
June 21, 2007 09:19 AM Eastern Daylight Time

<shortened url>

Effectiveness Shown in Relapsing Remitting Subjects Across Both Phase I/II Dose Escalation and Extension Trials

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced positive top-line data in an open-label Phase I/II extension clinical trial of the investigational ...
Read more : News on the Tovaxin Extension Trials | Views : 2203 | Replies : 4 | Forum : Tcelna (Tovaxin)


Phase III, Dignan?

Hi Dignan et al,
I haven't posted or read for a long time...pls excuse any data that may need repeated here but could you off the top of your head update when the drugs currently in phase III might be available? You did did this for me last September and the info has been invaluable.

Lee
Read more : Phase III, Dignan? | Views : 2524 | Replies : 9 | Forum : Drug Pipeline


Markov transitional model

Never heard of this before. Anyone?

Markov model predicts short-term disability in multiple sclerosis
Source: Reuters
Author:
Date: Fri, 22 June 2007

The findings published in the June 12th issue of Neurology support the novel use of a Markov transitional model in predicting the short-term disability in patients with multiple sclerosis (MS).

The standard statistical methods of survival analysis used to create clinical predictive models do not include the ongoing changing nature of MS, Dr. ...
Read more : Markov transitional model | Views : 1018 | Replies : 0 | Forum : General Discussion


Walking Into Things

Hi all,

Just a little effort to try and laugh at something that would be easy to get upset about...since the MS, my peripheral vision hasn't been the same. So, when I'm not looking directly at something, I may miss out on something. Yesterday, after my first attempt at returning to exercise for awhile, something caught my eye while walking towards the exit of the club. I walked forward and reached my hand out to ...
Read more : Walking Into Things | Views : 2475 | Replies : 8 | Forum : Daily Life


 

Login  •  Register


Statistics

Total posts 223869 • Total topics 23316 • Total members 14752


Contact us | Terms of Service